To create a vaccine against cancer

Researchers from the UK have developed a vaccine against prostate cancer in the late stages, which destroys the tumor without affecting healthy tissue. In laboratory experiments failed to kill 80% of malignant cells.

According to the creators of the vaccine, it is a completely new approach to treatment Prostate Cancer . Clinical trials on humans should begin within a few years. Although the vaccine was originally developed by scientists to combat it is with prostate cancer, experts believe that it may be effective in the fight against other cancers, including tumors of the breast, lung and pancreas.

Modern vaccines are usually given to people to prevent infection. But created by experts from the University of Leeds, the vaccine has been used since the disease attacked the man. Lead researcher Professor Alan Melcher is optimistic about the future and waiting for clinical trials in humans.

"So far, the vaccine for the treatment of prostate cancer appears safe - he said. - And if it is such a will, if we do not find any serious side effects, then after a couple of years can begin to human trials. Our vaccine works for by stimulating the immune system to recognize antigen - specific proteins present on cell surfaces. "

Most vaccines "teach" the body to seek and destroy the viruses or bacteria. British vaccine, which is a new word in the gene therapy causes an immune response to fight existing and distributed through the body by cancer cells.

Industry News

Go back to the main page